252 related articles for article (PubMed ID: 23233625)
1. Thrombocytopenia and bleeding in pediatric oncology patients.
Bercovitz RS; Josephson CD
Hematology Am Soc Hematol Educ Program; 2012; 2012():499-505. PubMed ID: 23233625
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusion goals in oncology patients.
Fasano RM; Josephson CD
Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion in hematology, oncology and surgery.
Wandt H; Schäfer-Eckart K; Greinacher A
Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
5. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.
Stanworth SJ
Hematology Am Soc Hematol Educ Program; 2012; 2012():512-6. PubMed ID: 23233627
[TBL] [Abstract][Full Text] [Related]
7. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Platelet Transfusion in Pediatric Patients.
Sloan SR; Parker RI
Transfus Med Rev; 2016 Oct; 30(4):230-4. PubMed ID: 27559006
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
[TBL] [Abstract][Full Text] [Related]
10. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
11. Platelet usage trends in a tertiary care hospital - Could it be less and less expensive?
Belen FB; Okur A; Kulali F; Egritas O; Kocak U; Kaya Z; Altuntas N; Yenicesu I
Transfus Apher Sci; 2012 Aug; 47(1):101-6. PubMed ID: 22592083
[TBL] [Abstract][Full Text] [Related]
12. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
[TBL] [Abstract][Full Text] [Related]
13. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
14. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
15. Neonatal and pediatric platelet transfusions: current concepts and controversies.
Patel RM; Josephson C
Curr Opin Hematol; 2019 Nov; 26(6):466-472. PubMed ID: 31503020
[TBL] [Abstract][Full Text] [Related]
16. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.
Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A
BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034
[TBL] [Abstract][Full Text] [Related]
19. Neonatal Platelet Transfusions and Future Areas of Research.
Sola-Visner M; Bercovitz RS
Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
[TBL] [Abstract][Full Text] [Related]
20. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.
Bercovitz RS; O'Brien SH
Hematology Am Soc Hematol Educ Program; 2012; 2012():157-60. PubMed ID: 23233575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
